Schumacher K, Haensch W, Röefzaad C, Schlag P M
Department of Surgery and Surgical Oncology, Charité, Humboldt University of Berlin, Lindenberger Weg 80, 13122 Berlin, Germany.
Cancer Res. 2001 May 15;61(10):3932-6.
The purpose of this study was to explore whether there is a linkage between the infiltration of CD8(+) T cells and the risk of death from esophageal cancer. Cases of 70 consecutive patients in whom esophageal squamous cell carcinomas ( n = 33) or adenocarcinomas (n = 37) were R0-resected between 1993 and 1999 were reviewed. The presence of activated CD8(+) T cells was evaluated by quantitative real-time PCR and immunohistochemistry and compared to clinical and pathological stages. The primary end point analyzed was overall survival, and a multivariate analysis was performed to distinguish any factors conferring an improved survivorship. Intratumoral (i.t.) CD8(+) T cells accumulating within the epithelial complexes were detected in 11 of all (16%) cases: in 9 of 25 (36%) patients with Union Internationale Contrele Cancer stage I or II versus 2 of 45 (4%) patients with Union Internationale Contrele Cancer stage III or IV (P = 0.001). Intratumoral CD8(+) T cell infiltrations showed proliferative activity and also IFN-gamma secretion. The presence of i.t. CD8(+) T cell infiltration more than peritumoral infiltration was associated with a good prognosis in both squamous cell and adenocarcinomas. Multivariate analysis showed that i.t. CD8(+) T cell infiltration was an independent prognostic factor (hazard ratio, 0.5; P = 0.0004) indicating favorable outcome. In conclusion, the presence of CD8(+) T cell infiltration in esophageal carcinomas is a favorable prognostic factor that should have diagnostic and therapeutic implications.
本研究的目的是探讨CD8(+) T细胞浸润与食管癌死亡风险之间是否存在联系。回顾了1993年至1999年间连续70例食管鳞状细胞癌(n = 33)或腺癌(n = 37)行R0切除的患者病例。通过定量实时PCR和免疫组织化学评估活化CD8(+) T细胞的存在情况,并与临床和病理分期进行比较。分析的主要终点是总生存期,并进行多变量分析以区分任何有助于提高生存率的因素。在所有病例中的11例(16%)中检测到在上皮复合体中积聚的肿瘤内(i.t.)CD8(+) T细胞:在国际抗癌联盟(Union Internationale Contrele Cancer)I期或II期的25例患者中的9例(36%),而在国际抗癌联盟III期或IV期的45例患者中的2例(4%)(P = 0.001)。肿瘤内CD8(+) T细胞浸润显示出增殖活性以及γ干扰素分泌。在鳞状细胞癌和腺癌中,肿瘤内CD8(+) T细胞浸润的存在超过肿瘤周围浸润均与良好预后相关。多变量分析显示,肿瘤内CD8(+) T细胞浸润是一个独立的预后因素(风险比,0.5;P = 0.0004),表明预后良好。总之,食管癌中CD8(+) T细胞浸润的存在是一个有利的预后因素,应具有诊断和治疗意义。